The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predictive and pharmacodynamic biomarkers of kinase inhibitors in renal cell carcinoma circulating tumor cells using the versa platform.
Joshua Michael Lang
Stock Ownership - Salus, LLC
Toni K. Choueiri
No relevant relationships to disclose
Stephanie Margaret Thiede
No relevant relationships to disclose
Jacob T Tokar
No relevant relationships to disclose
Lindsay Nicole Strotman
Stock Ownership - Salus, LLC
Benjamin Pun Casavant
Stock Ownership - Salus, LLC
Jamie M Sperger
No relevant relationships to disclose
Rana R. McKay
No relevant relationships to disclose
Edwin Jason Abel
No relevant relationships to disclose
Scott Michael Berry
Stock Ownership - Salus, LLC
David J. Beebe
Stock Ownership - Salus, LLC